Form 10-Q Vuzix Corp For: Jun 30

August 15, 2016 6:09 AM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

þ	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended June 30, 2016

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 001-35955

VUZIX CORPORATION

(Exact name of registrant as specified in its charter)

Delaware		04-3392453
State or other jurisdiction of incorporation or organization		(I.R.S. Employer Identification No.)

25 Hendrix Road, Suite A West Henrietta, New York		14583
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (585) 359-5900

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨

Accelerated filer ¨

Non-accelerated filer ¨

(Do not check if a smaller reporting company)

Smaller reporting company þ

Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act). Yes ¨ No þ

As of August 15, 2016, there were 17,356,161 shares of the registrant’s common stock outstanding.

Vuzix Corporation

INDEX

		Page No.

Part I – Financial Information		3

Item 1.	Condensed Consolidated Financial Statements (Unaudited):	3

	Consolidated Balance Sheets as of June 30, 2016 and December 31, 2015	3

	Consolidated Statement of Changes in Stockholder’s Equity for the Six Months Ended June 30, 2016	4

	Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2016 and 2015	5

	Consolidated Statement of Cash Flows for the Six Months Ended June 30, 2016 and 2015	6

	Notes to the Unaudited Condensed Consolidated Financial Statements	7

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	16

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	28

Item 4.	Controls and Procedures	28

Part II – Other Information		29

Item 1.	Legal Proceedings	29

Item 1A.	Risk Factors	29

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	29

Item 3.	Defaults Upon Senior Securities	29

Item 4.	Mine Safety Disclosure	29

Item 5.	Other Information	29

Item 6.	Exhibits	30

Signatures		31

Part 1: FINANCIAL INFORMATION

Item 1:

Condensed Consolidated Financial Statements

VUZIX CORPORATION

CONSOLIDATED BALANCE SHEETS

	(Unaudited)
	June 30,			December 31,
	2016			2015
ASSETS
Current Assets
Cash and Cash Equivalents	$	4,586,333		$	11,877,058
Accounts Receivable		101,883			325,694
Inventories, Net		3,470,954			3,349,098
Manufacturing Vendor Prepayments		424,574			369,411
Prepaid Expenses and Other Assets		869,000			608,950

Total Current Assets		9,452,744			16,530,211

Fixed Assets, Net		2,551,228			2,015,433
Patents and Trademarks, Net		520,403			515,697
Software Development Costs, Net		358,063			501,288

Total Assets	$	12,882,438		$	19,562,629

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities
Accounts Payable	$	1,057,169		$	907,434
Current Portion of Long-Term Debt, net of discount		1,468,396			55,790
Customer Deposits		34,970			27,847
Unearned Revenue		261,135			69,481
Accrued Expenses		915,062			734,497
Income and Other Taxes Payable		18,400			7,073

Total Current Liabilities		3,755,132			1,802,122

Long-Term Liabilities
Long-Term Derivative Liability		238,799			240,786
Long-Term Portion of Term Debt, net of discount		—			1,227,550
Long-Term Portion of Accrued Expenses		33,333			38,333
Long-Term Portion of Accrued Interest		—			160,967

Total Long-Term Liabilities		272,132			1,667,636

Total Liabilities		4,027,264			3,469,758

Stockholders’ Equity
Preferred Stock — $.001 Par Value, 5,000,000 Shares Authorized; 49,626 Shares Issued and Outstanding June 30, 2016, and December 31, 2015		50			50
Common Stock — $.001 Par Value, 100,000,000 Shares Authorized; 16,155,529 Shares Issued and Outstanding June 30, 2016 and 16,087,951 on December 31, 2015		16,156			16,088
Additional Paid-in Capital		74,307,065			73,665,601
Accumulated Deficit		(65,468,097	)		(57,588,868	)

Total Stockholders’ Equity		8,855,174			16,092,871

Total Liabilities and Stockholders’ Equity	$	12,882,438		$	19,562,629

The accompanying notes are an integral part of these consolidated financial statements.

VUZIX CORPORATION

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

(Unaudited)

	Preferred Stock				Common Stock				Additional		Accumulated
	Shares		Amount		Shares		Amount		Paid-In Capital		Deficit			Total

Balance — December 31, 2015		49,626	$	50		16,087,951	$	16,088	$	73,665,601	$	(57,588,868	)	$	16,092,871

Stock Based Compensation Expense										349,206					349,206
Conversion of Note Payable & Accrued Interest						10,000		10		22,490					22,500
Exercise of Warrants						15,000		15		44,985					45,000
Common Stock Award						10,000		10		50,790					50,800
Stock Issues for Services						32,578		33		173,993					174,026
Net Loss for the Six Months Ended June 30, 2016												(7,879,229	)		(7,879,229	)

Balance — June 30, 2016		49,626	$	50		16,155,529	$	16,156	$	74,307,065	$	(65,468,097	)	$	8,855,174

The accompanying notes are an integral part of these consolidated financial statements.

VUZIX CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	For Three Months						For Six Months
	Ended June 30,						Ended June 30,
	2016			2015			2016			2015

Sales of Products	$	421,377		$	427,812		$	785,217		$	1,123,386
Sales of Engineering Services		139,500			—			139,500			113,581

Total Sales		560,877			427,812			924,717			1,236,967

Cost of Sales — Products		647,871			392,548			1,250,848			977,938
Cost of Sales — Engineering Services		39,060			—			39,060			45,432

Total Cost of Sales		686,931			392,548			1,289,908			1,023,370

Gross Profit (Loss) (exclusive of depreciation shown separately below)		(126,054	)		35,264			(365,191	)		213,597
Operating Expenses:
Research and Development		1,669,043			732,491			2,943,756			1,247,198
Selling and Marketing		651,547			345,262			1,778,046			702,809
General and Administrative		1,199,427			1,023,244			2,085,744			3,958,149
Depreciation and Amortization		183,686			78,548			352,874			138,187

Loss from Operations		(3,829,757	)		(2,144,281	)		(7,525,611	)		(5,832,746	)

Other Income (Expense)
Interest Income		3,324			—			12,779			—
Other Taxes		(13,904	)		(2,290	)		(34,625	)		(14,065	)
Foreign Exchange (Loss) Gain		(3,536	)		(4,223	)		(7,484	)		1,048
Gain (Loss) on Derivative Valuation		(99,679	)		(23,279	)		1,987			(1,026,706	)
Amortization of Senior Term Debt Discount		(114,816	)		(178,981	)		(236,022	)		(519,941	)
Amortization of Deferred Financing Costs		(11,580	)		(11,580	)		(23,160	)		(23,032	)
Interest Expenses		(33,542	)		(37,693	)		(67,093	)		(77,737	)

Total Other Income (Expense)		(273,733	)		(258,046	)		(353,618	)		(1,660,433	)

Loss Before Income Taxes		(4,103,490	)		(2,402,327	)		(7,879,229	)		(7,493,179	)
Provision (Benefit) for Income Taxes		—			—			—			—

Net Loss		(4,103,490	)		(2,402,327	)		(7,879,229	)		(7,493,179	)
Preferred Stock Dividends		(399,715	)		(376,545	)		(793,540	)		(735,483	)

Loss Attributable to Common Stockholders	$	(4,503,205	)	$	(2,778,872	)	$	(8,672,769	)	$	(8,228,662	)

Loss per Share
Basic and Diluted Loss per Share (Note 2)	$	(0.28	)	$	(0.17	)	$	(0.54	)	$	(0.56	)
Weighted-average Shares Outstanding Basic and Diluted		16,137,419			15,934,279			16,135,881			14,754,298

The accompanying notes are an integral part of these condensed consolidated financial statements

VUZIX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	For the Six Months Ended
	June 30,
	2016			2015

Cash Flows from Operating Activities
Net Loss	$	(7,879,229	)	$	(7,493,179	)
Non-Cash Adjustments
Depreciation and Amortization		352,874			138,187
Amortization of Software Development Costs in Cost of Sales products		143,225			143,225
Common Stock Awards Compensation Expense		50,800			1,475,000
Stock Based Option Compensation Expense		349,206			252,331
Amortization of Term Debt Discount and Debt Issuance Costs		259,182			542,973
Common Stock and Warrants Issued for Services		124,874			821,121
(Gain) Loss on Derivative Valuation		(1,987	)		1,026,706
(Increase) Decrease in Operating Assets
Accounts Receivable		223,811			299,153
Inventories		(121,856	)		(174,889	)
Vendor Prepayments		(55,163	)		(687,681	)
Prepaid Expenses and Other Assets		(210,899	)		(90,547	)
Increase (Decrease) in Operating Liabilities
Accounts Payable		149,734			(1,495,169	)
Accrued Expense		179,151			20,770
Customer Deposits		7,123			(98,678	)
Unearned Revenue		191,654			15,188
Income and Other Taxes Payable		11,327			(28,426	)
Accrued Interest & Long-Term Accrued Interest Converted		(160,967	)		43,954

Net Cash Flows Used in Operating Activities		(6,387,140	)		(5,289,961	)

Cash Flows from Investing Activities
Purchases of Tooling and Equipment		(836,541	)		(171,243	)
Purchases of Marketable Securities		—			(5,000,000	)
Investments in Patents and Trademarks		(56,834	)		(126,975	)

Net Cash Used in Investing Activities		(893,375	)		(5,298,218	)

Cash Flows from Financing Activities
Proceeds from Exercise of Warrants		45,000			1,217,626
Repayment of Capital Leases		—			(10,873	)
Repayment of Long-Term Debt and Notes Payable		(55,210	)		(141,883	)
Proceeds from Preferred Stock Offering		—			24,813,000
Issuance Costs on Preferred Stock Offering		—			(214,169	)
Net Change in Line of Credit		—			(112,500	)

Net Cash Flows (Used in ) Provided by Financing Activities		(10,210	)		25,551,201

Net (Decrease) Increase in Cash and Cash Equivalents		(7,290,725	)		14,963,022
Cash and Cash Equivalents — Beginning of Period		11,877,058			84,967

Cash and Cash Equivalents — End of Period	$	4,586,333		$	15,047,989
Supplemental Disclosures
Interest Paid in Cash	$	11,444		$	25,495
Common Stock and Warrants Issued for Services, Initially Classified as Prepaid Expense	$	174,025		$	843,937
Conversion of Long-Term Debt and Accrued Interest	$	22,500		$	427,500
Reclassification of Derivative Liability to Paid-In Capital upon Waiver of Certain Anti-Dilutive Provisions of Warrants and Convertible Debt	$	—		$	11,543,354
Reclassification of Derivative Liability Upon Warrant Exercises	$	—		$	2,855,463

The accompanying notes are an integral part of these condensed consolidated financial statements.

VUZIX CORPORATION AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1 — Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements of Vuzix Corporation and Subsidiaries (“the Company") have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission. Accordingly, the unaudited Condensed Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The condensed consolidated balance sheet as of December 31, 2015 was derived from the audited Consolidated Financial Statements in Form 10-K.

The accompanying Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of the Company as of December 31, 2015, as reported in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission.

The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year.

For the six months ended June 30, 2016 one customer accounted for approximately 22% of sales. There was no single customer in the 2015 period that accounted for over 10% of total sales. Accounts receivable as of June 30, 2016 is 64% composed of amounts owed by that same customer.

The accompanying Condensed Consolidated Financial Statements have been prepared assuming that we will continue as a going concern. This basis of accounting contemplates the recovery of our assets and the satisfaction of liabilities in the normal course of business. These Condensed Consolidated Financial Statements do not include any adjustments to the specific amounts and classifications of assets and liabilities, which might be necessary should we be unable to continue as a going concern. The net loss for the first six months of 2016 was $7,879,229. The Company has incurred a net loss consistently over the last 2 years. The Company incurred annual net losses of $13,427,478 in 2015 and $7,868,858 in 2014, and has an accumulated deficit of $65,468,097 as of June 30, 2016.

The Company’s cash requirements are primarily for funding operating losses, working capital, research, debt service and capital expenditures. Our cash requirements related to funding operating losses depend on numerous factors, including new product development activities, our ability to commercialize our products, our products’ timely market acceptance, selling prices and gross margins, and other factors. Historically, the Company has met these cash needs by borrowings under notes, sales of convertible debt, and the sales of equity.

On July 11, 2016, the Company closed its public offering of 1,150,000 shares of common stock, at a public offering price of $5.75 per share. Total gross proceeds from the public offering were $6,612,500. Net proceeds after underwriting discounts and commissions and other offering expenses payable by Vuzix were approximately $5,996,000.

On January 2, 2015, the Company closed a sale of Series A Preferred Stock to Intel Corporation (the “Series A Private Placement”), for an aggregate purchase price of $24,813,000. Since the closing of the Company’s Series A Private Placement in January 2015, the Company has had the financial resources to better execute on its business plan. However, the Company will need to become profitable and continue implementing a focused new product development plan that can help grow revenues within reasonable timeframes.

The Company will need to grow its business significantly to become profitable and self-sustaining on a cash flow basis or it will be required to raise new capital. The Company in the second half of 2016 will begin shipping all new models and products as compared to its offerings in 2015. However, if these products are not successful within a reasonable time period, we will have to raise additional capital to maintain operations and/or materially reduce our operating and new product development costs.

If the Company raises additional funds by these methods, the ownership interest of existing stockholders may be diluted. The amount of such dilution could increase due to the issuance of new warrants or securities with other dilutive characteristics, such as full ratchet anti-dilution clauses or price resets.

However, there can be no assurance that we will be able to raise capital in the future or that if we raise additional capital it will be sufficient to execute our business plan. To the extent that we are unable to raise sufficient additional capital, we will be required to substantially modify our business plan and our plans for operations, which could have a material adverse effect on us and our financial condition.

Note 2 – Loss Per Share

Basic loss per share is computed by dividing the loss by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution from the assumed exercise of stock options and warrants, and the conversion of any convertible debt and convertible preferred shares. During periods of net loss, all common stock equivalents are excluded from the diluted EPS calculation because they are antidilutive. Since the Company reported a net loss for the three and six months ended June 30, 2016 and 2015, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potential common shares is anti-dilutive. As of June 30, 2016 and December 31, 2015, there were 7,324,230 and 7,366,036 respectively, common stock share equivalents potentially issuable under convertible debt agreements, conversion of preferred shares, options, and warrants that could potentially dilute basic earnings per share in the future.

Note 3 — Inventories, Net

Inventories are stated at the lower of cost (determined on the first-in, first-out or specific identification method) or market and consisted of the following:

	June 30, 2016			December 31, 2015

Purchased Parts and Components	$	3,217,769		$	3,069,261
Work in Process		505,110			154,880
Finished Goods		343,477			612,451
Less: Reserve for Obsolescence		(595,402	)		(487,494	)
Net	$	3,470,954		$	3,349,098

Note 4 — Accrued Expenses

Accrued expenses consisted of the following:

	June 30, 2016		December 31, 2015

Accrued Wages and Related Costs	$	84,538	$	102,792
Accrued Compensation		358,719		358,719
Accrued Professional Services		79,208		89,000
Accrued Warranty Obligations		55,997		64,002
Accrued Interest		326,600		109,984
Other Accrued Expenses		10,000		10,000

Total	$	915,062	$	734,497

Included in the above accrued compensation are amounts owed to officers of the Company for services rendered that remain outstanding. The amounts were $327,469 as of June 30, 2016 and December 31, 2015. The related interest amounts on the officer’s accrued compensation included in Accrued Interest were $115,051 and $97,801 respectively as of June 30, 2016 and December 31, 2015. These amounts are not subject to a fixed repayment schedule and they bear interest at a rate of 8% per year, compounding monthly. The related interest expense amounts for the six months ended June 30, 2016 and 2015 were $17,249 and $18,171 respectively.

The Company has warranty obligations in connection with the sale of certain of its products. The warranty period for its products is generally one year except in certain European countries where it is two years. The costs incurred to provide for these warranty obligations are estimated and recorded as an accrued liability at the time of sale. The Company estimates its future warranty costs based on product-based historical performance rates and related costs to repair. The changes in the Company’s accrued warranty obligations for the six months ended June 30, 2016 were as follows:

Accrued Warranty Obligations at December 31, 2015	$	64,002
Reductions for Settling Warranties		(31,173	)
Warranties Issued During Period		23,168

Accrued Warranty Obligations at June 30, 2016	$	55,997

Note 5 – Derivative Liability and Fair Value Measurements

The Company recognized a derivative liability for the warrants to purchase shares of its common stock issued in connection with the equity offering and related debt conversions on August 5, 2013. Those warrants have a cashless exercise provision and an exercise price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions) along with full-ratchet anti-dilution provisions. In accordance with FASB ASC 815-10-25, we measured the derivative liability using a Monte Carlo Options Lattice pricing model at their issuance date and subsequently remeasured the liability on each reporting date.

Accordingly, at the end of each quarterly reporting date, the derivative fair market value is remeasured and adjusted to current market value. As at June 30, 2016 and December 31, 2015 a total of 45,100 warrants were outstanding that contained a full-ratchet anti-dilution provision. In connection with the closing of the Series A Private Placement on January 2, 2015, holders of approximately 86% of outstanding warrants issued by the Company in its 2013 public offering and in connection with the conversion by certain holders of the Company’s outstanding debt in connection with the Company’s public offering (collectively, the “Public Offering Warrants”) agreed to irrevocably waive their rights to anti-dilution protection under Section 2(b) of the Public Offering Warrants in the event the Company issues additional securities at a per share price lower than the exercise price of the Public Offering Warrants (the “Public Offering Warrant Waiver”). As a result the related derivative liability was reversed to Nil on January 2, 2015 and reclassified into stockholders equity under Additional Paid-in Capital.

The Company recognized a derivative liability during the year ended December 31, 2014 for the $3,000,000 of senior convertible notes issued on June 3, 2014, with a conversion price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). In accordance with FASB ASC 815-10-25, we measured the derivative liability of this embedded conversion option using a Monte Carlo Options Lattice pricing model at the June 3, 2014 issuance date as $1,938,988. The value of the derivative liability at issuance was recorded as a discount against the notes in the Long-Term Liabilities section of the balance sheet. Accordingly, at the end of each quarterly reporting date the derivative fair market value is remeasured and adjusted to current market value.

In connection with the closing of the Series A Private Placement on January 2, 2015, each of the holders of notes issued by the Company on June 3, 2014 (the “June 2014 Notes”) agreed to irrevocably waive their rights to anti-dilution protection under Section 5(b) of the June 2014 Notes in the event the Company issues additional securities at a per share price lower than the conversion price of the June 2014 Notes (the “June 2014 Note Waiver”). As a result this derivative liability was reversed to Nil and reclassified into stockholders equity under Additional Paid-in Capital.

The Company has adopted FASB ASC Topic 820 for financial instruments measured at fair value on a recurring basis. FASB ASC Topic 820 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB ASC Topic 820 establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

- Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;

- Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

- Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

The carrying amount of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximates their fair value due to their short maturity. The carrying amount of notes payable approximates fair value because stated or implied interest rates approximate current interest rates that are available for debt with similar terms.

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at June 30, 2016:

	Total		Level 1		Level 2		Level 3

Warrant Liability	$	238,799	$	—	$	—	$	238,799
Total liabilities measured at fair value (Long-Term)	$	238,799	$	—	$	—	$	238,799

We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2015:

	Total		Level 1		Level 2		Level 3
Warrant Liability	$	240,786	$	—	$	—	$	240,786
Total liabilities measured at fair value (Long-Term)	$	240,786	$	—	$	—	$	240,786

Fair value – December 31, 2015	$	240,786

Change in fair value for the period of warrant derivative liability		(1,987	)

Fair value – June 30, 2016	$	238,799

The Monte Carlo Options Lattice pricing model was used to estimate the fair value of the warrants outstanding:

	June 30, 2016			December 31, 2015
Assumptions for Pricing Model:
Expected term in years		2.10			2.60
Volatility		108	%		103	%
Risk-free interest rate		0.71	%		1.06	%
Expected annual dividends		None			None

Value of warrants outstanding:
Fair value of warrants	$	238,799		$	240,786

Fluctuations in the variables used in calculating the value of the Company’s derivative liability could have a significant impact on the resulting valuation.

Note 6 — Long-Term Debt

Long-term debt consisted of the following:

	June 30, 2016			December 31, 2015

Note payable for research and development equipment. The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months. The note carries a 0% interest rate.	$	21,665		$	59,917
The note carries a 0% interest rate, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal.		(8,434	)		(21,085	)
Note payable for which the principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. The loan bears interest at 12% per year and is secured by a subordinated position in all the assets of the Company.		—			16,958
Convertible, Senior Secured Notes payable. The principal is due June 3, 2017 and no principal payments are required prior to maturity. The notes carry a 5% interest rate, payable upon the notes’ maturity. Both the principal plus accrued interest is convertible into shares of the Company’s common stock at $2.25 per share, subject to normal adjustments. The notes are secured by a first security position in all the assets of the Company.		1,896,240			1,915,155
Convertible, Senior Secured Notes Payable Issuance Costs of $139,340, net of accumulated amortization. The estimated aggregate amortization expense is approximately $23,000 for the remainder of fiscal 2016 and approximately $20,000 in the following fiscal year.		(42,914	)		(66,074	)
Unamortized debt discount related to derivative liability associated with above notes’ conversion price that was subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988.		(398,161	)		(621,531	)

		1,468,396			1,283,340
Less: Amount Due Within One Year		(1,468,396	)		(55,790	)

Amount Due After One Year	$	—		$	1,227,550

The calendar year aggregate maturities for all long-term debt exclusive of discounts as of June 30, 2016 are as follows:

Total Aggregate Maturity For Period	Amounts

2016	$	21,665
2017		1,896,240
Total Required Principal Payments Exclusive of Debt Discounts		1,917,905
Total Unamortized Debt Discounts and Deferred Costs		(449,509	)

Total Net Long-Term Borrowings as of June 30, 2016	$	1,468,396

Of the Convertible, Senior Secured Notes, a total of $18,915 were converted into 8,407 shares of common stock and a total of $3,585 of accrued interest on these Notes were converted into 1,593 shares of common stock during the six months ended June 30, 2016.

Note 7 — Income Taxes

The Company’s effective income tax rate is a combination of federal, state and foreign tax rates and differs from the U.S. statutory rate due to taxes on foreign income, permanent differences including tax-exempt interest, and the resolution of tax uncertainties, offset by a valuation allowance against U.S. deferred income tax assets.

Note 8 — Capital Stock

Preferred stock

The Company may issue shares of undesignated preferred stock in one or more series. The Board of Directors is authorized to establish and designate the different series and to fix and determine their voting powers and other special rights and qualifications. A total of 5,000,000 shares of preferred stock are authorized as of June 30, 2016 and December 31, 2015, 49,626 of which are designated as Series A Preferred Stock.

There were 49,626 shares of Series A Preferred Stock issued and outstanding on June 30, 2016 and December 31, 2015.

On January 2, 2015 the Company closed a sale of Series A Preferred Stock to Intel Corporation (the “Series A Purchaser”), pursuant to which we issued and sold an aggregate of 49,626 shares of the Company’s Series A Preferred Stock, at a purchase price of $500 per share, for an aggregate purchase price of $24,813,000. Each share of Series A Preferred Stock is convertible, at the option of the Series A holder, into 100 shares of the Company’s common stock (determined by dividing the Series A Original Issue Price of $500 by the Series A Conversion Price. The Series A Conversion Price is $5.00, subject to adjustment in the event of stock splits, dividends or other combinations).

Each share of Series A Preferred Stock is entitled to receive dividends at a rate of 6% per year, compounded quarterly and payable in cash or in kind, at the Company’s sole discretion. As of June 30, 2016, total accrued and unpaid preferred dividends were $2,307,621. As of December 31, 2015, total accrued and unpaid preferred dividends were $1,514,081. There were no declared preferred dividends owed as of June 30, 2016 or December 31, 2015.

The Series A Purchaser has the right, but not the obligation, to participate in any proposed issuance by the Company of its securities, subject to certain exceptions and in such amount as is sufficient to maintain the Series A Purchaser’s ownership percentage in the Company, calculated immediately prior to such applicable financing, at a purchase price equal to the per share price of the Company’s securities in such applicable financing.

In connection with the Series A Private Placement, the Company entered into an investor’s rights agreement with the Series A Purchaser, pursuant to which the Company agreed to file a “resale” registration statement with the Securities and Exchange Commission (the “SEC”) covering the resale of all shares of common stock issuable upon conversion of the Series A Preferred Stock. The Company’s registration statement covering the resale of these shares was declared effective by the SEC on February 17, 2015.

Common Stock

The Company’s authorized common stock consists of 100,000,000 shares, par value of $0.001 as of June 30, 2016 and December 31, 2015. There were 16,155,529 and 16,087,951 shares of common stock issued and outstanding as of June 30, 2016 and December 31, 2015, respectively.

Note 9 — Stock Warrants

A summary of the various changes in warrants during the six-month period ended June 30, 2016 is as follows:

	Number of Shares			Weighted Average Exercise Price

Outstanding at December 31, 2015		535,091		$	2.43
Issued During the Period		—			—
Exercised During the Period		(15,000	)		3.00
Expired During the Period		—			—

Outstanding at June 30, 2016		520,091		$	2.37

The outstanding warrants as of June 30, 2016 expire from November 3, 2017 to August 5, 2018. The weighted average remaining term of the warrants is 1.8 years.

A total of $45,000 in cash was received from warrant exercises for the six months ended June 30, 2016. No warrants were exercised in the six months ended June 30, 2015.

Note 10 — Stock Option Plans

A summary of stock option activity for the six months ended June 30, 2016 is as follows:

	Number of Shares			Weighted Average Exercise Price

Outstanding at December 31, 2015		1,022,789		$	4.59
Granted		7,500			5.69
Exercised		—			—
Expired or Forfeited		(31,523	)		5.58

Outstanding at June 30, 2016		998,766		$	4.57

The weighted average remaining contractual term for all options as of June 30, 2016 and December 31, 2015 was 7.1 years and 7.6 years respectively.

As of June 30, 2016, there were 518,054 options that were fully vested and exercisable at a weighted average exercise price of $5.02 per share. The weighted average remaining contractual term on the vested options is 7.2 years.

As of June 30, 2016 there were 480,712 unvested options exercisable at a weighted average exercise price of $4.07 per share. The weighted average remaining contractual term on the unvested options is 7.1 years.

No options were exercised during the six months ended June 30, 2016 and 2015.

The weighted average fair value of option grants was calculated using the Black-Scholes-Merton option pricing method. At June 30, 2016, the Company had approximately $1,874,254 of unrecognized stock compensation expense, which will be recognized over a weighted average period of approximately 1.8 years.

The aggregate intrinsic value that would have been received by the option holders had all holders exercised their options on June 30, 2016 was $3,461,296. The value represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the second quarter of fiscal year 2016 and the exercise price, multiplied by the number of in-the-money stock options). The amount of this aggregate intrinsic value will change based on the fair market value of the Company’s stock.

The following summary table shows the assumptions used to the fair value of options granted during the six-month period ended June 30, 2016 and their estimated value:

• Expected term in years		7.9 years
• Volatility		109.7	%
• Risk-free interest rate		1.68	%
• Expected annual dividends		None
• Fair value of options issued	$	37,755

Note 11 — Litigation

We are not currently involved in any current or pending legal proceeding or litigation.

Note 12 — Contractual Obligations

The Company has signed several lease agreements, with the largest being for its new office and manufacturing space under an operating lease that commenced October 3, 2015, that expires on October 3, 2020. The Company also leases small office spaces in England under a two-year lease and under a one year lease arrangement in Japan.

Future minimum payments required under operating lease obligations as of June 30, 2016 are as follows:

	Total Minimum Lease Payments
2016 (6 months)	$	194,098
2017		346,039
2018		335,248
2019		335,248
2020		279,373
Total	$	1,490,006

Under the lease agreements described above, the Company is required to pay the pro rata share of the real property taxes and assessments, expenses and other charges associated with these facilities.

Rent expense for the six months ended June 30, 2016 and 2015 totaled $246,704 and $38,197, respectively.

Note 13 — Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09 ("ASU 2014-09"), Revenue from Contracts with Customers, an updated standard on revenue recognition. The ASU will supersede most of the existing revenue recognition requirements in GAAP and will require entities to recognize revenue at an amount that reflects the consideration to which a company expects to be entitled in exchange for transferring goods or services to a customer. This ASU also amends the required disclosures of the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The guidance is effective for annual periods beginning after December 15, 2017, including interim periods within that period. Early adoption is permitted for annual periods beginning after December 15, 2016. The Company is determining its implementation approach and evaluating the potential impacts of the new standard on its existing revenue recognition policies and procedures.

In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements – Going Concern”, which provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity will be required to provide certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. The ASU applies to all entities and is effective for annual periods ending after December 15, 2016, and interim periods thereafter, with early adoption permitted. We are currently evaluating the impact of the adoption of ASU 2014-15 on our consolidated financial statements and have not yet determined when we will adopt the standard.

In July 2015, the Financial Accounting Standards Board (“FASB”) issued guidance which requires inventory within the scope of the standard to be measured at the lower of cost and net realizable value. Previous guidance required inventory to be measured at the lower of cost or market (where market was defined as replacement cost, with a ceiling of net realizable value and floor of net realizable value less a normal profit margin). The updated guidance is effective for interim and annual reporting periods beginning after December 15, 2016, with early adoption permitted. The Company is currently evaluating the impact, if any, the adoption of this standard will have on the consolidated financial statements.

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (ASU) 2016-02, Leases (Topic 842). Current U.S. generally accepted accounting principles (GAAP) requires lessees and lessors to classify leases as either capital leases or operating leases. Lessees recognize assets and liabilities for capital leases but do not recognize assets and liabilities for operating leases. ASU 2016-02 requires lessees to recognize assets and liabilities for all leases (with an exception for short-term leases). The new FASB guidance will be effective for fiscal years beginning after December 15, 2018, and interim periods thereafter. The Company is currently evaluating the impact, if any, the adoption of this standard will have on the consolidated financial statements.

In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (ASU) No. 2016-09, “Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting,” which amends the current stock compensation guidance. The amendments simplify the accounting for the taxes related to stock based compensation, including adjustments to how excess tax benefits and a company's payments for tax withholdings should be classified. The standard is effective for fiscal periods beginning after December 15, 2016, with early adoption permitted. The Company is evaluating the impact, if any, the adoption of this standard will have on the consolidated financial statements and related disclosures.

In April 2016, the Financial Account Standards Board (“FASB”) issued Accounting Standards Update (ASU) No. 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing” to clarify two aspects of Topic 606: (i) identifying performance obligations and (ii) the licensing implementation guidance, while retaining the related principles for those areas. The Company is evaluating the impact, if any, the adoption of this standard will have on the consolidated financial statements and related disclosures.

There are no other recent accounting pronouncements that are expected to have a material impact on the condensed consolidated financial statements.

Note 14 — Subsequent Events

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion and analysis of financial condition and results of operations in conjunction with the financial statements and related notes appearing elsewhere in this quarterly report and in our annual report on Form 10-K for the year ended December 31, 2015.

As used in this report, unless otherwise indicated, the terms “Company,” “Vuzix” “management,” “we,” “our,” and “us” refer to Vuzix Corporation and its subsidiary.

Critical Accounting Policies and Significant Developments and Estimates

The discussion and analysis of our financial condition and results of operations are based on our unaudited condensed consolidated financial statements and related notes appearing elsewhere in this quarterly report. The preparation of these statements in conformity with generally accepted accounting principles requires the appropriate application of certain accounting policies, many of which require us to make estimates and assumptions about future events and their impact on amounts reported in our financial statements, including the statement of operations, balance sheet, cash flow and related notes. We continually evaluate our estimates used in the preparation of our financial statements, including those related to revenue recognition, bad debts, inventories, warranty reserves, product warranty, carrying value of long-lived assets, fair value measurement of financial instruments and embedded derivatives, valuation of stock compensation awards, and income taxes. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about carrying values of assets and liabilities that are not apparent from other sources. Since future events and their impact cannot be determined with certainty, the actual results will inevitably differ from our estimates. Such differences could be material to the financial statements.

We believe that our application of accounting policies, and the estimates inherently required therein, are reasonable. We periodically reevaluate these accounting policies and estimates, and make adjustments when facts and circumstances dictate a change. Historically, we have found our application of accounting policies to be appropriate, and actual results have not differed materially from those determined using necessary estimates.

Management believes certain factors and trends are important in understanding our financial performance. The critical accounting policies, judgments and estimates that we believe have the most significant effect on our financial statements are:

•

valuation of inventories;

•

carrying value of long-lived assets;

•

software development costs

•

revenue recognition;

•

product warranty;

•

fair value measurement of financial instruments and embedded derivatives;

•

stock-based compensation; and

•

income taxes.

Our accounting policies are more fully described in the notes to our condensed consolidated financial statements included in this quarterly report and in our annual report on Form 10-K for the year ended December 31, 2015. There have been no significant changes in our accounting policies for the six month period ended June 30, 2016.

Off Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have, or are reasonably likely to have, an effect on our financial condition, financial statements, revenues or expenses.

Business Matters

We are engaged in the design, manufacture, marketing and sale of wearable display and computing devices that are worn like eyeglasses and feature built-in video screens that enable the user to view video and digital content, such as movies, computer data, the Internet or video games. Our wearable display products, known commercially as Video Eyewear, Smart-Glasses, Augmented Reality (AR) and Virtual Reality (VR) products contain micro video displays that offer users a portable high-quality viewing experience. Our wearable display products provide virtual large high-resolution screens, that can fit in a user’s pocket or purse and can be viewed practically anywhere, anytime. They can also be used for VR and AR applications, in which the wearer is either immersed in a computer generated world or has his real world view augmented with computer generated information or graphics. Smart Glasses, a new category of wearable displays that have much of the capabilities of a smartphone including wireless internet access but are worn like glasses which allow for hands-free operation ideal for enterprise users. We produce both monocular and binocular devices. Vuzix wearable displays are designed to work as standalone devices or with mobile electronic devices, such as cell phones, laptop computers, tablets, portable media players and gaming systems.

All our wearable display products feature high performance miniature display modules, low power electronics and related optical systems. Our Smart Glasses products also feature powerful mobile computers, camera, voice recognition, and WiFi/Bluetooth radios for wireless communications. We produce both monocular and binocular wearable display devices that we believe are leading solutions for many mobile computer or video viewing requirements. We have a focus on the consumer markets for gaming, VR and mobile video uses, while our Smart Glasses and AR products are directed primarily to the enterprise, commercial, and medical markets. The consumer electronics and mobile phone accessory markets in which we compete have been subject to rapid technological change including the rapid adoption of tablets, larger screen sizes and display resolutions on mobile phones, along with declining prices on these products, and as a result we must continue to improve our products’ performance and lower our costs. We believe our intellectual property portfolio gives us a competitive position in microdisplay electronics, waveguides, ergonomics, packaging, motion tracking and optical systems.

Recent Accounting Pronouncements

There are no other recent accounting pronouncements that are expected to have a material impact on the condensed consolidated financial statements.

Results of Operations

Comparison of Three Months Ended June 30, 2016 and June 30, 2015

The following table compares the Company’s consolidated statements of operations data for the three months ended June 30, 2016 and 2015.

	3 Months Ended June 30,
	2016			2015			Dollar Change			% Increase (Decrease)

Sales of Products	$	421,377		$	427,812		$	(6,435	)		(2	)%
Sales of Engineering Services		139,500			—			139,500			100	%

Total Sales		560,877			427,812			133,065			31	%

Cost of Sales — Products		647,871			392,548			255,323			65	%
Cost of Sales — Engineering Services		39,060			—			39,060			100	%

Total Cost of Sales		686,931			392,548			294,383			75	%

Gross Profit (Loss)		(126,054	)		35,264			(161,318	)		(457	)%
Gross Profit (Loss) %		(22	)%		8	%

Operating Expenses:
Research and Development		1,669,043			732,491			936,552			128	%
Selling and Marketing		651,547			345,262			306,285			89	%
General and Administrative		1,199,427			1,023,244			176,183			17	%
Depreciation and Amortization		183,686			78,548			105,138			134	%

Loss from Operations		(3,829,757	)		(2,144,281	)		(1,685,476	)		79	%

Other Income (Expense)
Other Taxes		(13,904	)		(2,290	)		(11,614	)		507	%
Foreign Exchange Gain (Loss)		(3,536	)		(4,223	)		687			(16	)%
Gain (Loss) on Derivative Valuation		(99,679	)		(23,279	)		(76,400	)		328	%
Amortization of Senior Term Debt Discount & Financing Costs		(126,396	)		(190,561	)		64,165			(34	)%
Interest Expense, net of Interest Income		(30,218	)		(37,693	)		7,475			(20	)%

Total Other Income (Expense)		(273,733	)		(258,046	)		(15,687	)		6	%

Loss Before Income Taxes		(4,103,490	)		(2,402,327	)		(1,701,163	)		71	%
Provision (Benefit) for Income Taxes		—			—			—			—

Net Loss	$	(4,103,490	)	$	(2,402,327	)	$	(1,701,163	)		71	%

Sales. The overall decrease in product sales for the three months ended June 30, 2016 over the same period in 2015 was primarily the result of a 12% decrease in sales of the M100 Smart Glasses, net of a 84% increase in waveguide product sales for the 2016 period versus the prior year’s period. After the announcement of the new M300 at CES in January 2016, many customers have delayed further purchases of our smart glasses until we commence shipping the M300. Pre-orders for the new M300 and new orders of our M100/M300 migration packages improved in the second quarter as compared to our first quarter of 2016. All of the M300 Preorders only packages are included in deferred revenues and will not be recognized as revenues until they ship to the customer. Our Video Headphone sales were 13% of product revenues for the three months ending June 30, 2016 versus $0 in the same period in 2015 when it was not yet available. Revenues from this product line during the second quarter of 2016 continue to be constrained due to production difficulties. For the 2015 comparative period, approximately 14% of total product revenues came from the Wrap series of products which was discontinued in the summer of 2015, and as a result no such product revenues were reported in the 2016 period. In summary, monocular smart glasses and waveguide product sales were 83% of total product revenues versus 84% in the prior period.

Sales from our engineering programs for the three months ended June 30, 2016, was $139,500 as compared to $0 in the same period in 2015 when we had no active programs. This waveguide product related engineering services program is currently expected to continue for the balance of our fiscal 2016.

Cost of Sales and Gross Profit (Loss). Cost of product revenues and engineering services is comprised of materials, components, labor, warranty costs, freight costs, manufacturing overhead, and the non-cash amortization of software development costs related to the production of our products and rendering engineering services. The decreased net gross profit (loss) percentage earned in the three months ended June 30, 2016 as compared to the same period in 2015 was primarily the result of lower sales levels to absorb many of our relatively fixed manufacturing overheads and amortization costs as well as $107,349 increase in freight costs for the 2016 period as compared to 2015. As our new iWear product is bulkier and heavier and ships in a larger retail package than our prior products, the costs of air shipments have become prohibitively material now that production volumes from China have risen and we are switching to sea transport later this summer as the volumes of shipments are expected to increase. The following table reflects the components of our cost of goods sold for products:

Component of Cost of Sales	3 Months Ended June 30, 2016			As % Related Sales			3 Months Ended June 30, 2015		As % of Related Sales			Dollar Change
Product Cost of Sales	$	362,999			86	%	$	125,813		29	%	$	237,186
Manufacturing Overhead		168,977			40	%		126,169		30	%		42,808
Warranty Costs		12,249			3	%		17,124		4	%		(4,875	)
Amortization of Software Costs		71,613			17	%		71,613		17	%		—
Software Royalties		32,033			8	%		51,829		12	%		(19,796	)

Total Cost of Sales – Products	$	647,871			154	%	$	392,548		92	%	$	255,323

Gross Profit (Loss)– Product Sales	$	(226,494	)		(54	)%	$	35,264		8	%	$	(261,758	)

Research and Development. Our research and development expenses consist primarily of compensation costs for personnel, related stock compensation expenses, third party services, purchase of research supplies and materials, and consulting fees related to research and development costs. Software development expenses to determine technical feasibility before final development and ongoing maintenance that are not capitalized are included in research and development costs.

Comparing the research and development costs for the three months ending June 30, 2016 versus the same period in 2015, there was an increase in 2016 salary, benefits and stock compensation expenses of $278,967, primarily the result of additional R&D staff versus the same period in 2015; an increase in project development and research costs of $533,881 primarily related to the new M300 Smart Glasses product development; an increase in $65,384 in rent and utility costs related to the expanded R&D portion of our new corporate facilities; an increase of $54,775 in external research related consulting fees; and a $12,801 increase in travel costs related to our China based iWear production contractor and development work at our new contractors facility of our forthcoming M300 Smart Glasses.

Selling and Marketing. Selling and marketing costs consist of trade show costs, advertising, travel costs, sales staff compensation costs including stock compensation expense, consulting fees, PR agency fees, website costs and sales commissions paid to full-time staff and outside consultants. These costs increased overall for the three months ended June 30, 2016 by $306,285 as compared to the same period in 2015 primarily due to the following factors: higher salary, commissions, benefits and stock compensation expenses related to new staff additions totaling $131,025; increased trade show costs of $45,120 due to larger exhibit booth sizes and show rentals during the quarter versus the same period in 2015; increased public relations costs of $16,886 due to the hiring of a second PR firm; a $58,099 increase in website costs including additions to our main new European website to match our main corporate website and e-store; and a $22,848 increase in travel costs.

Depreciation and Amortization. Depreciation and amortization expense for the quarter ended June 30, 2016 was $183,686 as compared to $78,548 in the same period in 2015, an increase of $105,138. The increase in depreciation and amortization expense is due to new investments in depreciable assets at our new facility during the second half of 2015 and early 2016.

Other Income (Expense). Total other expense was $273,733 for the three months ended June 30, 2016 compared to an expense of $258,046 in the same period in 2015. The increase in expenses was primarily the result of an increased loss of $76,400 on the derivative liability valuation mark-to-market revaluation for the 2016 period versus the prior 2015 quarter loss partially offset by a reduction of $64,165 in senior debt discount and issuance expense amortization for the 2016 period versus 2015.

Provision (Benefit) for Income Taxes. There were no provisions for income taxes for the three months ended June 30, 2016 or 2015.

Comparison of Six Months Ended June 30, 2016 and June 30, 2015

The following table compares the Company’s consolidated statements of operations data for the six months ended June 30, 2016 and 2015.

	6 Months Ended June 30,
	2016			2015			Dollar Change			% Increase (Decrease)

Sales of Products	$	785,217		$	1,123,386		$	(338,169	)		(30	)%
Sales of Engineering Services		139,500			113,581			25,919			23	%

Total Sales		924,717			1,236,967			(312,250	)		(25	)%

Cost of Sales — Products		1,250,848			977,938			272,910			28	%
Cost of Sales — Engineering Services		39,060			45,432			(6,372	)		(14	)%

Total Cost of Sales		1,289,908			1,023,370			266,538			26	%

Gross Profit (Loss)		(365,191	)		213,597			(578,788	)		(271	)%
Gross Profit (Loss) %		(39	)%		17	%

Operating Expenses:
Research and Development		2,943,756			1,247,198			1,696,558			136	%
Selling and Marketing		1,778,046			702,809			1,075,237			153	%
General and Administrative		2,085,744			3,958,149			(1,872,405	)		(47	)%
Depreciation and Amortization		352,874			138,187			214,687			155	%

Loss from Operations		(7,525,611	)		(5,832,746	)		(1,692,865	)		29	%

Other Income (Expense)
Other Taxes		(34,625	)		(14,065	)		(20,560	)		146	%
Foreign Exchange Gain (Loss)		(7,484	)		1,048			(8,532	)		(814	)%
Gain (Loss) on Derivative Valuation		1,987			(1,026,706	)		1,028,693			(100	)%
Amortization of Senior Term Debt Discount & Financing Costs		(259,182	)		(542,973	)		283,791			(52	)%
Interest Expense, net of Interest Income		(54,314	)		(77,737	)		23,423			(30	)%

Total Other Income (Expense)		(353,618	)		(1,660,433	)		1,306,815			(79	)%

Loss Before Income Taxes		(7,879,229	)		(7,493,179	)		(386,050	)		5	%
Provision (Benefit) for Income Taxes		—			—			—			—

Net Loss	$	(7,879,229	)	$	(7,493,179	)	$	(386,050	)			5%

Sales. The decrease in product sales for the six months ended June 30, 2016 over the same period in 2015 was primarily the result of a 33% decrease in sales of the M100 Smart Glasses. After the announcement of the new M300 at CES in January 2016, many customers have delayed further purchases of our smart glasses until we commence shipping the M300 Smart Glasses. Pre-orders for these new M300 are included in deferred revenues and will not be recognized as revenues until they ship to the customer. Our iWear Video Headphones sales were 12% of product revenues for the six months ending June 30, 2016 versus $0 in the same period in 2015 when it was not yet available. Revenues from this product line during the first half of 2016 continue to be constrained due to production difficulties. For the 2015 comparative period, approximately 15% of revenues came from the Wrap series of products which was discontinued in the summer of 2015, whereas no such product revenues were reported in the 2016 period. In summary, monocular smart glasses and waveguide product sales were 85% of total product revenues versus 83% in the prior period.

Sales from our engineering services programs for the six months ended June 30, 2016, were $139,500 or 15% of total revenues as compared to $113,581 or 9% of total sales in the same period in 2015. We have one waveguide product related engineering services program which is currently expected to continue for the balance of our fiscal 2016.

Cost of Sales and Gross Profit (Loss). Cost of product revenues and engineering services is comprised of materials, components, labor, warranty costs, freight costs, manufacturing overhead, and the non-cash amortization of software development costs related to the production of our products and rendering engineering services. The decreased net gross profit (loss) percentage earned in the six months ended June 30, 2016 as compared to the same period in 2015 was primarily the result of lower sales levels to absorb many of our relatively fixed manufacturing overheads and amortization costs; as well as increased manufacturing overhead costs of $61,436 due to additional staff and larger plant facilities costs, component material scrapping costs of $89,523 related to iWear Video Headphones in the first quarter of 2016; as well as a $127,661 increase in freight costs for the 2016 period as compared to 2015. The following table reflects the components of our cost of goods sold for products:

Component of Cost of Sales	6 Months Ended June 30, 2016			As % Related Sales			6 Months Ended June 30, 2015		As % of Related Sales			Dollar Change
Product Cost of Sales	$	713,329			91	%	$	470,084		42	%	$	243,245
Manufacturing Overhead		316,038			40	%		254,602		23	%		61,436
Warranty Costs		23,168			3	%		45,072		4	%		(21,904	)
Amortization of Software Costs		143,225			18	%		143,225		12	%		—
Software Royalties		55,088			7	%		64,955		6	%		(9,867	)

Total Cost of Sales – Products	$	1,250,848			159	%	$	977,938		87	%	$	272,910

Gross Profit (Loss)– Product Sales	$	(465,631	)		(59	)%	$	145,448		13	%	$	(611,079	)

Comparing the research and development costs for the six months ending June 30, 2016 versus the same period in 2015, there was an increase in 2016 salary, benefits and stock compensation expenses of $720,043, primarily the result of additional R&D staff versus the same period in 2015; an increase in project development and research costs of $744,268 primarily related to the new product development for the M300 Smart Glasses; an increase in $119,722 in rent and utility costs related to the expanded R&D portion of our new corporate facilities; an increase of $57,709 in external research related consulting fees; and a $57,836 increase in travel costs related to our China based iWear production contractor and development work at our new contractors facility of our forthcoming M300 Smart Glasses.

Selling and Marketing. Selling and marketing costs consist of trade show costs, advertising, travel costs, sales staff compensation costs including stock compensation expense, consulting fees, PR agency fees, website costs and sales commissions paid to full-time staff and outside consultants. These costs increased overall for the six months ended June 30, 2016 by $1,075,659 as compared to the same period in 2015 primarily due to the following factors: higher salary, commissions, benefits and stock compensation expenses related to new staff additions totaling $278,754; increased trade show costs of $319,629 due to larger exhibit booth sizes and show rentals and attendance at two additional trade shows during the quarter versus the same period in 2015; increased public relations costs of $133,954 due the hiring of two new PR firms as compared to the 2015 period; new 2016 period video production costs of $53,433; a $180,541 increase in website costs including additions to our main new corporate and European websites; a $66,854 increase in travel costs; and a $23,252 increase in rent costs.

General and Administrative. General and administrative costs include professional fees, investor relations (IR) costs including shares and warrants issued for IR services, salaries and related stock compensation, travel costs, office and rental costs. These costs decreased by $1,872,405 or 47% for the six months ended June 30, 2016 as compared to the same period in 2015 primarily because of: lower compensation expense related to stock awards totaling $1,375,000 to our officers and directors awarded in January 2015; a $21,082 decrease in travel costs; decreased IR activities and IR consultant fees of $553,540 resulting from reductions in compensation awards of shares and warrants for these services as compared to the 2015 period; $117,863 decrease in legal fees, of which $100,000 of this decrease is related to a stock award made to our attorneys in January 2015; partially offset by: an increase of $20,367 in fees paid to our external board members as compared to the 2015 period when lower fee arrangements were in place; a $47,962 increase in accounting and audit fees, with the majority of the change being for SOX consultants retained to assist management in designing and implementing improvements in our financial reporting controls, as compared to the same period in 2015 when no such consultants were retained and increased rent and occupancy costs of $36,937 due to our larger corporate offices.

Depreciation and Amortization. Depreciation and amortization expense for the six months ended June 30, 2016 was $352,874 as compared to $138,187 in the same period in 2015, an increase of $214,687. The increase in depreciation and amortization expense is due to new investments in depreciable assets at our new facility during the second half of 2015 and early 2016 and some still in use assets no being fully depreciated.

Other Income (Expense). Total other expense was $353,618 for the six months ended June 30, 2016 compared to an expense of $1,660,433 in the same period in 2015. The $1,306,815 reduction in expenses was primarily the result of a gain of $1,987 on the derivative liability valuation mark-to-market revaluation for the 2016 period versus a loss of $1,026,706 in the prior 2015 quarter, and a reduction of $283,791 in senior debt discount and issuance expense amortization for the 2016 period versus 2015.

Provision (Benefit) for Income Taxes. There were no provisions for income taxes for the six months ended June 30, 2016 or 2015.

Liquidity and Capital Resources

As of June 30, 2016, we had cash and cash equivalents of $4,586,333, a decrease of $7,290,725 from $11,877,058 as of December 31, 2015.

At June 30, 2016 we had current assets of $9,452,744 compared to current liabilities of $3,755,132 which resulted in a positive working capital position of $5,697,612. At December 31, 2015, we had current assets of $16,530,211 compared to current liabilities of $1,802,122 which resulted in a working capital position of $14,728,089. Our current liabilities are comprised principally of accounts payable and accrued expenses.

Operating Activities. We used $6,387,140 of cash for operating activities for the six months ending June 30, 2016 and $5,289,961 in the same period in 2015, primarily the result of an increased operating loss after adding back non-cash items. The major changes in operating assets and liabilities for 2016 resulted from a $210,899 increase in prepaid expenses, a $223,811 decrease in accounts receivable and a $149,734 increase in accounts payable. The major operating items for the six month period ending June 30, 2015 were a $1,495,169 decrease in accounts payable, a $687,681 increase in vendor component deposits and a $174,889 increase in inventory, offset by a $299,153 reduction in accounts receivable and a $90,547 reduction in prepaid expenses.

Investing Activities. Cash used in investing activities was $893,375 for the six months ending June 30, 2016 as compared to $298,218 in the same period in 2015, excluding marketable security investments in the 2015 period. During the first half of 2016, $836,541 was used primarily for the purchase of leasehold improvements for our new clean room equipment for our new manufacturing facility as well as additions to product tooling and computer equipment additions, as compared to spending of $171,243 for the same period in 2015, primarily for the purchase of manufacturing equipment and mold tooling, as well as computer equipment additions. The costs of registering our intellectual property rights, included in the investing activities totals described above, were $56,834 in the six month period ending June 30, 2016 and $126,975 in the same period in 2015.

Financing Activities. We used $10,210 of cash for financing activities for the six months ending June 30, 2016 as compared to generating $25,551,201 of cash from financing activities in 2015. For the 2016 period, financing activities consisted of the repayment of $55,210 in notes payable and the receipt of $45,000 from cash warrant exercises. During the six months ended June 30, 2015, the primary sources of cash from financing activities were the proceeds of $24,813,000 from the sale of Series A Preferred Stock on January 2, 2015 to Intel Corporation (discussed below), less direct offering costs of $214,169 and the cash proceeds of $1,217,626 from warrant exercises.

Capital Resources. As of June 30, 2016, we had a cash balance of $4,586,333.

The net loss for the first six months of 2016 was $7,879,229. The Company incurred annual net losses of $13,427,478 in 2015 and $7,868,858 in 2014, and has an accumulated deficit of $65,468,097 as of June 30, 2016. The Company will need to grow its business significantly to become profitable and self-sustaining on a cash flow basis or it will be required to raise new capital. The Company’s management intends to take actions necessary to continue as a going concern, and accordingly our condensed consolidated financial statements included in this report have been prepared assuming that we will continue as a going concern. This basis of accounting contemplates the recovery of our assets and the satisfaction of liabilities in the normal course of business. These condensed consolidated financial statements do not include any adjustments to the specific amounts and classifications of assets and liabilities, which might be necessary should we be unable to continue as a going concern.

The Company’s cash requirements are primarily for funding operating losses, working capital, research, debt service and capital expenditures. On July 11, 2016, the Company closed its public offering of 1,150,000 shares of common stock, at a public offering price of $5.75 per share. Total net proceeds from the public offering were approximately $5,996,000, after underwriting discounts and commissions and other offering expenses payable by Vuzix. On January 2, 2015 we closed a Series A Preferred Stock sale to Intel Corporation, for an aggregate purchase price of $24,813,000. Since the closing of the Company’s Series A Private Placement in January 2015, the Company has had the financial resources to better execute on its business plan. Our cash requirements related to funding operating losses depend on numerous factors, including new product development activities, our ability to commercialize our products, our products’ timely market acceptance, selling prices and gross margins, and other factors. In order for us to achieve positive cash flow from operations, our product sales will need to significantly increase. The Company in the second half of 2016 will be shipping all new models and products as compared to its offerings in 2015. However, if these products are not successful within a reasonable time period, we will have to raise additional capital to maintain operations and/or materially reduce our operating and new product development costs.

Historically, the Company has met its cash needs by borrowings under notes, sales of convertible debt, and the sales of equity. If the Company raises additional funds by these methods, the ownership interest of existing shareholders may be diluted. The amount of such dilution could increase due to the issuance of new warrants or securities with other dilutive characteristics, such as full ratchet anti-dilution clauses or price resets.

Operationally in 2016, manufacturing yield issues with our new iWear Video Headphones continued all through the first quarter of 2016 and well into the second quarter of 2016, and as a result we were not able to produce at anywhere near our planned production rates. During this period we learned that while we could manufacture units in sufficient volume, their optical performance was not up to specification and that further component quality improvements were required. We have completed these further revisions and are now transitioning these new components and processes back to our China-based volume manufacturer. These changes along with sea rather than air freight shipments, should reduce our manufacturing and transportation costs and greatly increase product availability for our fall selling season. Despite these production challenges we continue to experience strong customer interest in Vuzix iWear and expect to finally implement our broader planned marketing and sales activities around iWear. We are expanding our sales and distribution channels with the recent appointment of North American distributors and resellers. Europe and Japan have recently commenced receiving iWear units and they are also signing up expanded distribution channels in anticipation of the seasonally strong fall selling season for consumer oriented goods like our iWear Video Headphones.

The announcement of our new M300 and M3000 Smart Glasses products has slowed our M100 Smart Glasses sales and delayed further pilots and roll-outs by many enterprise customers that prefer to employ the latest proven technology. And as there are many improvements offered by the upcoming M300 and M3000 Smart Glasses, customers have been waiting. The commencement of our promotional package in February 2016 that allows such customers to easily upgrade their new M100 purchase to an M300 when it is available or place pre-orders for the M300 has been seeing some modest success. However we have been reporting most of these sales as deferred revenue or deposits.

In the remainder of 2016 we expect to achieve growing revenues from our iWear Video Headphones, continuing sales of our M100s and starting in October volume production of our new M300s.

We are continuing our waveguide development and ramp up for volume production later this year. Positive further strides are being made in waveguide performance, clarity, component materials and tightly controlled replication techniques. Pursuant to these activities in June 2016 we announced an additional waveguide focused OEM collaboration partner and are exploring further third party collaboration and development agreements that will utilize our waveguides in augmented reality solutions.

Regarding our new waveguide based products, the M3000 waveguide smart glasses have been released to production engineering for tooling. The B3000, our first fashion smart glasses are expected to be released in 2017.

We believe our existing cash and cash equivalent balances and improvements in our cash requirements for future operations will, if we successfully implement our operating plan, be sufficient to meet our working capital and capital expenditure needs for the foreseeable future even with continued operating losses for the next two quarters. There can, however be no assurance that we will be able to generate positive cash flows from operations in near the future thereafter.

Forward Looking Statements

This quarterly report includes forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on our management’s beliefs and assumptions and on information currently available to our management. Forward-looking statements include statements concerning:

Our cash needs and financing plans;

Our possible or assumed future results of operations;

Our business strategies;

Our ability to attract and retain customers;

Our ability to sell additional products and services to customers;

Our competitive position;

Our industry environment;

Our potential growth opportunities;

Expected technological advances by us or by third parties and our ability to leverage them;

The effects of future regulation; and

The effects of competition.

All statements in this quarterly report that are not historical facts are forward-looking statements. We may, in some cases, use terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” “would” or similar expressions that convey uncertainty of future events or outcomes to identify forward-looking statements.

The outcome of the events described in these forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements.

All such forward-looking statements are subject to certain risks and uncertainties and should be evaluated in light of important risk factors. These risk factors include, but are not limited to, those that are described in “Risk Factors” under Item 1A and elsewhere in our 2015 annual report on Form 10-K and other filings we make with the Securities and Exchange Commission and the following: business and economic conditions, rapid technological changes accompanied by frequent new product introductions, competitive pressures, dependence on key customers, inability to gauge order flows from customers, fluctuations in quarterly and annual results, the reliance on a limited number of third party suppliers, limitations of our manufacturing capacity and arrangements, the protection of our proprietary technology, the effects of pending or threatened litigation, the dependence on key personnel, changes in critical accounting estimates, potential impairments related to investments, foreign regulations, liquidity issues, and potential material weaknesses in internal control over financial reporting. Further, during weak or uncertain economic periods, customers’ may delay the placement of their orders. These factors often result in a substantial portion of our revenue being derived from orders placed within a quarter and shipped in the final month of the same quarter.

Any of these factors could cause our actual results to differ materially from our anticipated results. We caution readers to carefully consider such factors. Many of these factors are beyond our control. In addition, any forward-looking statements represent our estimates only as of the date they are made, and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, except as may be required under applicable securities laws, we specifically disclaim any obligation to do so, even if our estimates change.

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Not required for a smaller reporting company.

Item 4.

Controls and Procedures

Disclosure Controls and Procedures

We maintain a system of disclosure controls and procedures designed to provide reasonable assurance that information required to be disclosed in reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s (SEC) rules and forms. Disclosure controls are also designed to reasonably assure that such information is accumulated and communicated to management, including the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate to allow timely decisions regarding required disclosure. Disclosure controls include components of internal control over financial reporting, which consists of control processes designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with GAAP.

As reported in our 2015 Annual Report on Form 10-K (the "2015 Form 10-K"), as of December 31, 2015, our management identified material weaknesses in our internal control over financial reporting that have a direct impact on our financial reporting. Due to these material weaknesses in internal control over financial reporting, our management concluded in our 2015 Form 10-K that our disclosure controls and procedures were ineffective as of December 31, 2015.

Our management, with the participation of our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of June 30, 2016. As part of its evaluation, our management has evaluated whether the control deficiencies related to the reported material weakness in internal control over financial reporting continue to exist. As of June 30, 2016, we have not completed the development, assessment, implementation and testing of the changes in controls and procedures that we believe are necessary to conclude that the material weakness has been remediated and, therefore, our management has concluded that we cannot assert that the control deficiencies relating to the reported material weakness have been effectively remediated. As a result, our CEO and CFO have concluded that our disclosure controls and procedures were ineffective as of June 30, 2016.

In light of the foregoing conclusion, we undertook additional procedures in order that management could conclude that reasonable assurance exists regarding the reliability of financial reporting and the preparation of the consolidated financial statements contained in this filing. Accordingly, management believes that our condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for the period ended June 30, 2016 fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented.

Changes in internal control over financial reporting

During the three months ended June 30, 2016, there were no changes in our internal controls that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Part II. OTHER INFORMATION

Item 1.

Legal Proceedings

We are not involved in any current or pending legal proceeding or litigation and we are not aware of any such proceedings contemplated by or against us or our property. To our knowledge, there are no material legal proceedings to which any our directors, officers or affiliates, or any beneficial owner of more than five percent of our common stock, or any associate of any of the foregoing, is a party adverse to us or any of our subsidiaries or has a material interest adverse to us or any of our subsidiaries.

Item 1A.

Risk Factors

In addition to the other information set forth in this report you should carefully consider the factors discussed in Part I, Item 1A. “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2015. There have been no material changes from those risk factors. The risks discussed in our 2015 annual report could materially affect our business, financial condition and future results.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

Sale of Unregistered Securities –

During the three months ended June 30, 2016 we issued 25,078 shares of common stock for investor relations services.

During the three months ended June 30, 2016, we issued 15,000 shares of common stock upon the exercise of warrants with an exercise price of $3.00 per share issued to a consultant for investor relations services.

During the three months ended June 30, 2016 we issued 10,000 shares of common stock to a new independent director of the Company as compensation,

In connection with the foregoing, we relied upon the exemption from registration provided by Section 4(a)(2) under the Securities Act of 1933, as amended, for transactions not involving a public offering.

Purchase of Equity Securities – none

Item 3.

Defaults Upon Senior Securities

None

Item 4.

Mine Safety Disclosures

Not Applicable

Item 5.

Other Information

None

Item 6.

Exhibits

Exhibit No.		Description

31.1		Certification of the Chief Executive Officer of the Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of the Chief Financial Officer of the Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1		Certification of the Chief Executive Officer of the Registrant pursuant to 18 U.S.C. Section 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Certification of the Chief Financial Officer of the Registrant pursuant to 18 U.S.C. Section 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Link base Document

101.DEF		XBRL Taxonomy Extension Definition Link base

101.LAB		XBRL Taxonomy Extension Label Link base Document

101.PRE		XBRL Taxonomy Extension Presentation Link base Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	VUZIX CORPORATION

Date: August 15, 2016	By:	/s/ Paul J. Travers
		Paul J. Travers
		President, Chief Executive Officer
		(Principal Executive Officer)

Date: August 15, 2016	By:	/s/ Grant Russell
		Grant Russell
		Executive Vice President and Chief Financial Officer
		(Principal Financial and Accounting Officer)

Exhibit 31.1

CERTIFICATION PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Paul J. Travers, certify that:

I have reviewed this quarterly report on Form 10-Q of Vuzix Corporation;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 15, 2016	/s/ Paul J. Travers
	Paul J. Travers
	President and Chief Executive Officer

Exhibit 31.2

CERTIFICATION PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Grant Russell, certify that:

I have reviewed this quarterly report on Form 10-Q of Vuzix Corporation;

(a)

(b)

(c)

(d)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 15, 2016	/s/ Grant Russell
	Grant Russell
	Executive Vice President and Chief Financial Officer

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Vuzix Corporation (“Vuzix”) on Form 10-Q for the quarterly period ended June 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Paul J. Travers, President and Chief Executive Officer of Vuzix, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Vuzix.

	/s/ Paul J. Travers
	Paul J. Travers
	President and Chief Executive Officer

Date: August 15, 2016

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Vuzix Corporation (“Vuzix”) on Form 10-Q for the quarterly period ended June 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Grant Russell, Chief Financial Officer of Vuzix, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Vuzix.

	/s/ Grant Russell
	Grant Russell
	Chief Financial Officer

Date: August 15, 2016

StreetInsider

Log in to your account:

Form 10-Q Vuzix Corp For: Jun 30

Categories

Next Articles